Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still roughly 24% below their early‑November high near $168. StockAnalysis+1 Over the past month, the stock has dropped almost 20%, even after Monday’s rebound, while it remains up around 10% year‑to‑date and down about 12% over the last 12 months. MarketBeat+1 That combination of strong year‑to‑date gains, a sharp recent sell‑off, and a big AI narrative makes Dell one of the
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and above its original target. Viking Therapeutics InvestorRoom As of yesterday’s close (Monday, November 24), VKTX changed hands at $34.65, implying a market capitalization of roughly $3.9 billion. Stock Titan Shares sit well below their 52‑week high of $56.25, but far above the 52‑week low of $18.92, underscoring how volatile the weight‑loss drug trade has become. Investing.com+1 With Phase 3 trials
DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest in compliance-focused AI.Simply Wall St+1 Now, heading into Tuesday, November 25, 2025, DGNX is back in the spotlight after the company signed a non‑binding memorandum of understanding (MOU) to acquire The Remedy Project, a specialist in human-rights risk and worker-centered remediation for global supply chains.ir.diginex.com+2Nasdaq+2 Below is a detailed look at where DGNX stock stands today, what’s driving the latest
25 November 2025
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

As investors head into the Tuesday, November 25 session, Pfizer Inc. (NYSE: PFE) remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that a new growth story is taking shape around obesity drugs, oncology and a large – and growing – dividend. As of late Monday trading, Pfizer shares were changing hands around $25 per share, giving the company a market value of roughly $143 billion and placing the stock in the middle of its 52‑week range between $20.92 and $27.69.StockAnalysis+1 At that
25 November 2025
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had a busy news day on Monday — and the stock still finished sharply lower. Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting the stock well below its recent highs despite a fresh U.S. FDA green light to advance a new depression treatment into Phase 2 trials. TNXP now trades near the lower end of its volatile 52‑week range of $6.76 to $130.00, with a market capitalization of about $168 million. StockAnalysis At the same time, Tonix is transitioning from a pure development-stage
25 November 2025
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Ticker: BIDU • Exchange: Nasdaq • Date: November 25, 2025 BIDU Stock Jumps as Wall Street Turns More Bullish Baidu’s U.S.-listed shares (NASDAQ: BIDU) rallied sharply on Monday, November 25, 2025, as investors digested fresh analyst upgrades and continued to reposition around the Chinese search and AI giant’s high-spend transformation. By the close, BIDU was trading around $119 per share, up roughly 7.5% on the day from Friday’s $110.95 close. Investing The move added billions of dollars to Baidu’s market value, lifting its market capitalization to around $41 billion. StockAnalysis The rally comes just days after Baidu reported a revenue
25 November 2025
Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy Co., Inc. (NYSE: BBY) heads into a critical earnings report tomorrow with its share price under pressure, its dividend yield hovering around 5%, and investors trying to gauge how tariffs and holiday demand will shape the next leg for the stock. On Monday, November 25, 2025, BBY slipped about 1.1% in regular trading to close at $75.62, underperforming a strong broader market rally, before rebounding modestly in after-hours trading to around $76.03.StockAnalysis+1 Below is a look at how BBY traded today, what Wall Street expects from tomorrow’s results, and the key themes that could move the stock through
25 November 2025
Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics Inc. (TSX‑V: PNG, OTCQB: KRKNF) finished Monday, November 24, 2025 modestly higher after reporting record third‑quarter results and reaffirming a robust full‑year outlook, underscoring the market’s ongoing interest in this fast‑growing subsea defense and robotics name. At the close, PNG.V traded at C$5.39, up C$0.03 on the day (+0.56%), on heavier‑than‑usual volume, leaving the marine technology company with a market capitalization of roughly C$1.6 billion. StockAnalysis PNG.V stock price today: modest gain on heavy volume Over the past 12 months, Kraken Robotics shares have climbed roughly 158%, reflecting investors’ enthusiasm for the company’s role in underwater defense and
MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

Published: November 24, 2025 Medical Properties Trust (NYSE: MPW) stock is trading around the mid‑$5s after a surprise dividend increase, a $150 million buyback and mixed Q3 2025 results. Here’s what today’s MPW stock action means for income investors, value hunters and short sellers. MPW stock price today: a quiet move after loud news Medical Properties Trust (NYSE: MPW) ended Monday trading in the low‑$5 range, around $5.30–$5.32 per share, roughly flat on the day and up less than 1% versus Friday’s close.MarketBeat Despite the modest intraday move, the backdrop is anything but quiet: In other words, MPW stock has
24 November 2025
LX Stock Today (November 24, 2025): LexinFintech Jumps on Strong Q3 Earnings and Steady 2025 Guidance

LX Stock Today (November 24, 2025): LexinFintech Jumps on Strong Q3 Earnings and Steady 2025 Guidance

LexinFintech Holdings Ltd. (NASDAQ: LX) shares pushed sharply higher on Monday after the Chinese fintech group reported robust third‑quarter 2025 earnings and reaffirmed its full‑year profit outlook despite tightening regulation in its home market. At the close of U.S. trading on November 24, LX finished around $3.78, up roughly 8% on the day. The stock traded between about $3.60 and $4.08, with turnover of just over 4 million ADSs, above its recent average volume of roughly 3.5 million shares.Finviz The move comes as investors digest a mixed but generally resilient Q3 report: profits are surging, revenue is slightly down, and
DFLI Stock Today (Nov. 24, 2025): Dragonfly Energy Pops on Werner Deal and Debt Reset

DFLI Stock Today (Nov. 24, 2025): Dragonfly Energy Pops on Werner Deal and Debt Reset

Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) — the Nevada-based lithium battery and energy storage company behind the Battle Born® brand — is back on traders’ radar today after announcing a key commercial order from Werner Enterprises and building on a recent balance-sheet overhaul. As of late trading on Monday, November 24, 2025, DFLI stock is changing hands around $0.79, up roughly 5% on the session after swinging between about $0.73 and $0.92 intraday. Below is a closer look at what’s driving the move, how the fundamentals are evolving, and what investors may want to watch next. DFLI stock today: price
BURU Stock Today (Nov. 24, 2025): Nuburu’s Defense-Tech Pivot Keeps Shares Around $0.21

BURU Stock Today (Nov. 24, 2025): Nuburu’s Defense-Tech Pivot Keeps Shares Around $0.21

Nuburu, Inc. (NYSE American: BURU) — the blue-laser specialist racing to reinvent itself as a defense and security platform — is trading quietly today, as investors digest a flurry of recent deals, a deep quarterly loss, and fresh funding for its key Italian partner Tekne. As of Monday afternoon, BURU is changing hands around $0.21 per share, up roughly 3% on the day, after trading in a range of roughly $0.205 to $0.214 on volume just above 25 million shares, versus a 20‑day average volume of about 52 million shares. StockAnalysis+3StockAnalysis+3Investing.com+3 Year to date, Nuburu is still up more than
BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

Ticker: NYSE: BFLYPublished: November 24, 2025 Butterfly Network (BFLY) is back on traders’ radar today. The digital health and handheld ultrasound company’s share price is surging after a cluster of bullish catalysts — including a new multi-year licensing deal, aggressive insider buying, fresh AI product news and continuing follow‑through from its latest earnings report. As of this afternoon on Monday, November 24, 2025, BFLY stock is trading around $3.28–$3.29, up roughly 24% versus its previous close in the mid‑$2.60s. Intraday, shares have traded between the high‑$2.80s and low‑$3.30s, with volume topping 16 million shares, far above average. MarketBeat+1 At these
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare Inc. (NYSE: MOH) shares bounced higher on Monday as traders reacted to fresh headlines about a possible extension of Affordable Care Act (ACA) subsidies, even as the managed-care insurer continues to grapple with margin pressure, new class‑action lawsuits and a sharp rerating of its valuation. As of Monday’s close, MOH stock finished at $145.30, up about 2.6% for the day after trading between the low $140s and low $150s. StockAnalysis The move extends a modest rebound off recent lows but barely dents a brutal sell‑off: Molina remains more than 50% below its 52‑week high of $359.97, with a
24 November 2025
BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025)

BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025)

BillionToOne (NASDAQ: BLLN) continued its powerful post‑IPO run on Monday, with shares of the precision diagnostics company closing near their recent highs and extending a rally that has already doubled the stock from its offering price earlier this month. As investors hunt for high‑growth healthcare names with a credible path toward profitability, BLLN has quickly become one of Wall Street’s most closely watched new listings. BLLN stock today: price, move, and key stats (Nov. 24, 2025) As of Monday’s close on November 24, 2025, BillionToOne stock traded with the following profile: StockAnalysis+1 At Monday’s close, BLLN trades just over 100%
24 November 2025
JXG Stock Soars After Reverse Split: Inside JX Luxventure’s Double‑Digit Rally on November 24, 2025

JXG Stock Soars After Reverse Split: Inside JX Luxventure’s Double‑Digit Rally on November 24, 2025

JX Luxventure Group Inc. (NASDAQ: JXG) bounced sharply on Monday, November 24, 2025, reversing part of a brutal multi‑week slide and drawing traders’ attention across the pre‑market and regular session. Data from multiple real‑time feeds shows JXG trading around $4.20 in late‑day action, up roughly 20–23% from Friday’s close near $3.45. Intraday prices ranged between about $3.50 and $4.30, with volume approaching 4.8 million shares, far above recent norms. Investing.com+2Investing.com+2 That surge comes just days after a 1‑for‑15 reverse stock split designed to keep the micro‑cap travel and e‑commerce name in compliance with Nasdaq listing rules. TipRanks Key Takeaways on
24 November 2025
CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

Monday, November 24, 2025 Clearside Biomedical’s CLSD stock is in freefall today after the eye‑disease biotech announced a voluntary Chapter 11 bankruptcy filing and plans to pursue a court‑supervised sale of its business and assets. By late afternoon on Monday, CLSD was trading around $0.88, down roughly 68% on the day, according to intraday pricing data from MarketBeat. MarketBeat+1 Earlier in the session, multiple outlets reported the shares sliding to roughly $0.85–$0.86 following the news, a collapse from Friday’s close at $2.69 and a new 52‑week low. TradingView+2Nasdaq+2 Key Takeaways for CLSD Stock Today CLSD Stock Price Today: A Collapse
24 November 2025
GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

On Monday, November 24, 2025, shares of Hyperscale Data Inc. (NYSE American: GPUS) were trading higher after the company announced it has joined the global top 100 public Bitcoin treasury companies, underscoring its transformation into a high‑beta bet on both AI data centers and Bitcoin. Stock Titan+1 As of mid‑afternoon trading, GPUS stock was changing hands at roughly $0.28, up about 12% on the day from a previous close near $0.25, with intraday prices ranging between roughly $0.27 and $0.29. StockAnalysis+1 While that bounce grabbed traders’ attention, the stock remains down more than 95% from its 52‑week high near $10,
CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

Cava Group (NYSE: CAVA) is ending November on a tense note. The Mediterranean fast‑casual chain that became one of 2023’s hottest IPOs is now grappling with slowing growth, a painful share‑price reset, and a market suddenly skeptical of “bowl‑based” fast casual. As of mid‑afternoon trading on Monday, November 24, 2025, CAVA stock is changing hands around $46.80, down roughly 4% on the day. That puts the stock only a few dollars above its 52‑week low near $43, and almost 70% below its 52‑week high around $153, underscoring how brutal the past year has been for shareholders. Yahoo Finance+1 Yet under
24 November 2025
1 598 599 600 601 602 606

Stock Market Today

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
ASML stock price snaps back as AI spending bets return, with ex-dividend date next

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

7 February 2026
ASML shares rose 3.84% Friday in Amsterdam to 1,193.80 euros, rebounding with global chip stocks after Amazon signaled a sharp increase in AI-related capital spending. The stock goes ex-dividend Feb. 9 ahead of a 1.60-euro interim payout. ASML’s Nasdaq shares climbed 4.64% to $1,413.01. Despite Friday’s gains, the Amsterdam listing finished the week about 2.5% lower.
Go toTop